Conference highlights key management strategies in public health and infectious diseases, suggesting new therapeutic approaches.
CIDSCON 2025 served as a dynamic platform where leaders in Infectious Diseases, Critical Care, Microbiology, and Public Health converged to deliberate on emerging clinical challenges and evolving therapeutic paradigms. Part I of this series laid the foundation by capturing the initial plenary discussions, core clinical themes, and high-impact debates, setting the stage for the deeper explorations and expanded insights presented in this second instalment. Each session summary captures essential themes—diagnostic reasoning, management strategies, stewardship principles, and evidence updates—while highlighting the distinct clinical wisdom shared by faculty. Through the collective work of dedicated rapporteurs, the academic spirit of CIDSCON 2025 continues to inform and inspire practice well beyond its original stage. This is Part 2 of our three-part series capturing key insights from CIDSCON 2025. Continue reading and watch out for the upcoming editions as we bring you more clinical pearls and conference highlights.
No takes yet. Share an insight, caveat, or question.
Ramabhadran et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: